Generic versions of semaglutide – the active ingredient in Ozempic and Wegovy – are beginning to enter the market in countries such as India and Canada.
News May 8, 2026More than 40,000 vetted patient stories are now featured on P4AD’s interactive map, representing every state and congressional district and documenting the harm of high drug prices.
News May 1, 2026The Supreme Court heard arguments this week in a case that could limit how and when lower-cost generics come to market.
News Apr 24, 2026Over the last two weeks, P4AD patient advocates from across the country traveled to Washington, D.C., to share what high drug prices mean in real terms — skipped doses, delayed care, and impossible financial tradeoffs.
News Apr 17, 2026The high cost of GLP-1 drugs are increasing pressure on state Medicaid programs — and in response, some cities and states are beginning to restrict or eliminate coverage.
News Apr 10, 2026AbbVie and Genentech have joined TrumpRx, bringing the total number of participating companies to 11 and the total number of drugs available through the platform to 69.
News Apr 3, 2026President Trump unveiled 100% tariffs on patented medications and their active ingredients in a move that could raise costs for patients.
News Mar 27, 2026A new P4AD analysis found that pharmaceutical companies raised prices on 208 rare disease drugs in the first week of the year, just months after the ORPHAN Cures Act was signed into law, weakening…
News Mar 20, 2026P4AD’s new analysis exposes a troubling pattern: pharmaceutical companies are raising prices on lifesaving HIV medications year after year, while simultaneously pushing to undermine reforms that…
News Mar 13, 2026In the last year, 29% of Americans delayed taking a vacation, 26% delayed medical treatment, and 11% skipped meals, all due to the high cost of healthcare.
1:49 · Watch on YouTube
3:50 · Watch on YouTube
0:51 · Watch on YouTube
